Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib

被引：62
|
作者：
Gambacorti-Passerini, Carlo [1 ]
Mussolin, Lara [2 ]
Brugieres, Laurence [3 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Univ Padua, Padua, Italy
[3] Gustave Roussy Canc Campus, Villejuif, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 01期
关键词：
LARGE-CELL LYMPHOMA;
D O I：
10.1056/NEJMc1511045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [1] Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma
    Zito Marino, Federica
    Morabito, Alessandro
    Gridelli, Cesare
    Rocco, Gaetano
    Liguori, Giuseppina
    De Rosa, Nicla
    Botti, Gerardo
    Franco, Renato
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (09) : E86 - E88
  • [2] Crizotinib in ALK-positive lung cancer
    Girard, Nicolas
    LANCET ONCOLOGY, 2012, 13 (10): : 962 - 963
  • [3] Ensartinib vs crizotinib in ALK-positive NSCLC
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E76 - E76
  • [4] Use of crizotinib for refractory ALK-positive lymphomas
    Shelikhova, L. N.
    Fominykh, V. V.
    Abramov, D. S.
    Myakova, N. V.
    Maschan, M. A.
    Maschan, A. A.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 51 - 56
  • [5] Brigatinib versus crizotinib for ALK-positive NSCLC
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (11): : E585 - E585
  • [6] Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
    Harrer, Dennis Christoph
    Menhart, Karin
    Mayer, Stephanie
    Herr, Wolfgang
    Reichle, Albrecht
    Vogelhuber, Martin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Refractory or relapsed ALK-positive anaplastic T large cell lymphoma treated with crizotinib
    Miaomiao, L.
    Zhang, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1758 - 1758
  • [8] Refractory ALK-Positive Anaplastic Large Cell Lymphoma: Long Term Survival with Crizotinib
    Ganesan, Prasanth
    Joshua, Thanda
    Sundersingh, Shirley
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 353 - 354
  • [9] Crizotinib in ALK-Positive Diffuse Large B-Cell Lymphoma: A Case Report
    Wass, Maxi
    Behlendorf, Timo
    Glaeser, Ulrike
    Ruessel, Joern
    Guentsch, Fredericke
    Karin, Jordan
    Schmoll, Hans-Joachim
    BLOOD, 2012, 120 (21)
  • [10] Crizotinib in ALK-positive diffuse large B-cell lymphoma: a case report
    Wass, M.
    Behlendorf, T.
    Schaedlich, B.
    Glaeser, U.
    Ruessel, J.
    Guentsch, F.
    Schmoll, H. -J
    Jordan, K.
    ONKOLOGIE, 2012, 35 : 41 - 41
12345